Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 批发和零售业
Company Introduction 益丰大药房连锁股份有限公司主要从事药品、保健品、医疗器械以及与健康相关的日用便利品等的连锁零售业务，子公司益丰医药作为公司内部集中采购平台，兼顾少量对外药品批发业务。公司坚持区域聚焦和直营门店战略。截至2014年12月31日，本公司及下属子公司在湖南、湖北、上海、江苏、浙江和江西等中南和华东的六省市开设810家连锁直营门店，总经营面积达122,072.20平方米，截至2014年12月31日，公司销售产品品规达1.57万余种，合作供应商1,210余家。根据MDC数据统计，公司2011年、2012年、2013年和2014年连续四年综合竞争力排名第六位，并获得2014年成长力冠军；根据《21世纪药店报》的数据统计，公司2013-2014年在中国连锁药店综合实力百强榜排名第五位。
Main Business 药品、保健品、医疗器械以及与健康相关的日用便利品等的连锁零售业务。
Legal Representative 高毅
Top Executives
董事长：高毅
董事：高峰,高佑成,徐新,叶崴涛,柴敏刚
独立董事：易兰广,王红霞,颜爱民
Top 5 Shareholder
Shareholder name Nature Holding Date
宁波梅山保税港区厚信创业投资合伙企业（有限合伙）流通A股21.65%31/03/2024
香港中央结算有限公司流通A股18.53%31/03/2024
高毅流通A股11.67%31/03/2024
CAPITAL TODAY INVESTMENT XV（HK）LIMITED流通A股9.61%31/03/2024
CAPITAL TODAY INVESTMENT XIV（HK）LIMITED流通A股9.55%31/03/2024
Company Secretary 范炜
Solicitors 湖南启元律师事务所
Auditors 天健会计师事务所（特殊普通合伙）
Tel No 0731-89953989
Fax No 0731-89953989
Website www.yfdyf.cn
Email ir@yfdyf.com
Company Address
Register: 湖南省常德市武陵区人民路2638号
Office: 湖南省长沙市麓谷高新区金洲大道68号
Listing Date 17/02/2015
Shares Capital
Shares Capital: 1,010,579,797
Total A Share: 1,010,579,797
Listed A Share: 1,008,116,102
Non-tradable A Share: 2,463,695
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 1.400
DPS(RMB)* ¥ 0.500
NBV Per Share(RMB)* ¥ 9.702
Market Capitalization(RMB) 44.710B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.